These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 1355924

  • 1. Differences between antipsychotic drugs in persistence of brain levels and behavioral effects.
    Cohen BM, Tsuneizumi T, Baldessarini RJ, Campbell A, Babb SM.
    Psychopharmacology (Berl); 1992; 108(3):338-44. PubMed ID: 1355924
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Chronic treatments with zotepine, thioridazine, and haloperidol affect apomorphine-elicited stereotypic behavior and striatal 3H-spiroperidol binding sites in the rat.
    Lai H, Carino MA, Horita A.
    Psychopharmacology (Berl); 1981; 75(4):388-90. PubMed ID: 6122233
    [Abstract] [Full Text] [Related]

  • 4. Scopolamine modulates apomorphine-induced behavior in rats treated with haloperidol or SCH 23390.
    Butkerait P, Friedman E.
    Eur J Pharmacol; 1988 Mar 29; 148(2):269-72. PubMed ID: 2897925
    [Abstract] [Full Text] [Related]

  • 5. Behavioural effects of chronic treatment with apomorphine in combination with neuroleptic drugs.
    Kenny M, Leonard BE.
    J Neurosci Res; 1980 Mar 29; 5(4):291-8. PubMed ID: 6107385
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Behavioral pharmacologic studies in the monkey with DD-3480.
    Shibuya T, Nishimori T, Matsuda H, Chen PC.
    Int J Clin Pharmacol Ther Toxicol; 1982 Jun 29; 20(6):251-4. PubMed ID: 6125481
    [Abstract] [Full Text] [Related]

  • 10. Behavioural correlates to the dopamine D-1 and D-2 antagonists.
    Christensen AV, Arnt J, Hyttel J, Svendsen O.
    Pol J Pharmacol Pharm; 1984 Jun 29; 36(2-3):249-64. PubMed ID: 6147830
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antistereotypic effects of dopamine D-1 and D-2 antagonists after intrastriatal injection in rats. Pharmacological and regional specificity.
    Arnt J.
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Aug 29; 330(2):97-104. PubMed ID: 2864641
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Reduction of dopaminergic supersensitivity by a single dose of amphetamine.
    Haracz JL, Tseng LF.
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Aug 29; 313(2):131-3. PubMed ID: 6106902
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.